Defunct Company
Total Trials
9
As Lead Sponsor
3
As Collaborator
6
Total Enrollment
502
NCT00490620
Study of Combivir for Patients With Primary Biliary Cirrhosis
Phase: Phase 2/3
Role: Collaborator
Start: Jan 31, 2004
Completion: Apr 30, 2007
NCT00134758
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
Start: Oct 31, 2004
Completion: Oct 31, 2009
NCT00322699
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
Phase: Phase 1/2
Start: Feb 28, 2005
Completion: Mar 31, 2011
NCT00470171
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2005
Completion: Nov 30, 2008
NCT00308399
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
Start: Nov 30, 2005
Completion: Jun 30, 2007
NCT00559052
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
Start: Mar 31, 2008
Completion: Feb 28, 2009
NCT00862901
Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma
Phase: Phase 1
Start: Jan 31, 2009
Completion: Apr 30, 2011
NCT01430234
Enzyme Suppletion in Exocrine Pancreatic Dysfunction
Phase: Phase 4
Start: Oct 31, 2011
Completion: Feb 28, 2013
NCT05187065
The Effect of Mobile-based Education and Exercise Program Given to Patients With Total Knee Replacement Surgery
Phase: N/A
Start: Feb 1, 2022
Completion: Dec 5, 2023